Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by OneDigital Investment Advisors LLC

OneDigital Investment Advisors LLC trimmed its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 15.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 378,431 shares of the company's stock after selling 67,884 shares during the period. OneDigital Investment Advisors LLC owned 0.31% of Privia Health Group worth $8,496,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of PRVA. Durable Capital Partners LP boosted its holdings in shares of Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company's stock worth $224,587,000 after acquiring an additional 378,255 shares during the period. Nuveen Asset Management LLC boosted its holdings in shares of Privia Health Group by 19.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company's stock worth $29,110,000 after acquiring an additional 246,393 shares during the period. Loomis Sayles & Co. L P boosted its holdings in shares of Privia Health Group by 55.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock worth $27,727,000 after acquiring an additional 503,002 shares during the period. Dimensional Fund Advisors LP boosted its stake in Privia Health Group by 10.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company's stock valued at $27,687,000 after buying an additional 138,747 shares during the period. Finally, Northern Trust Corp boosted its stake in Privia Health Group by 14.2% during the fourth quarter. Northern Trust Corp now owns 1,392,641 shares of the company's stock valued at $27,226,000 after buying an additional 173,563 shares during the period. 94.48% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently issued reports on PRVA shares. Robert W. Baird lifted their price objective on Privia Health Group from $24.00 to $26.00 and gave the company an "outperform" rating in a research note on Tuesday, April 15th. Barclays lifted their price objective on Privia Health Group from $23.00 to $24.00 and gave the company an "equal weight" rating in a research note on Tuesday, May 27th. Needham & Company LLC reissued a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research note on Thursday, April 10th. JPMorgan Chase & Co. lifted their price objective on Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a research note on Wednesday, May 28th. Finally, Truist Financial lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research note on Thursday, April 10th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $27.77.

Privia Health Group Trading Up 0.8%

Shares of NASDAQ:PRVA traded up $0.17 during trading on Tuesday, reaching $21.52. The company's stock had a trading volume of 807,482 shares, compared to its average volume of 765,555. Privia Health Group, Inc. has a 12 month low of $16.47 and a 12 month high of $26.09. The firm's 50 day simple moving average is $23.01 and its two-hundred day simple moving average is $22.92. The stock has a market capitalization of $2.62 billion, a PE ratio of 179.35, a price-to-earnings-growth ratio of 3.42 and a beta of 0.82.

Insider Buying and Selling

In other news, Director Matthew Shawn Morris sold 10,309 shares of the company's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $240,508.97. Following the transaction, the director directly owned 59,792 shares of the company's stock, valued at approximately $1,394,947.36. This represents a 14.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Parth Mehrotra sold 15,100 shares of the company's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $352,283.00. Following the transaction, the chief executive officer directly owned 454,281 shares in the company, valued at approximately $10,598,375.73. The trade was a 3.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,949 shares of company stock valued at $1,100,368 over the last 90 days. Corporate insiders own 10.70% of the company's stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.